Last updated on August 2018

A Phase 1 Trial to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PC-6500 (Griffithsin [GRFT] in a Carrageenan Gel) in Healthy Women

Brief description of study

We are looking for healthy, HIV negative women using birth control to participate in a study of an experimental vaginal gel. The purpose of the study is to see if the gel is safe to be used in women when used daily for 14 days. The study is a total of 10 visits, including screening. Participation involves blood draws, HIV and STI testing, pregnancy testing, pelvic exams, and cervical and vaginal biopsies. Compensation is provided. 


Clinical Study Identifier: TX154680

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )